Febrile Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing and-Nonproducing Bacteria: A Comparative Study
![]() |
Ahn, Do Hee
(Department of Pediatrics, Graduate School of Medicine, Gachon University)
Kim, Kyu Won (Department of Pediatrics, Graduate School of Medicine, Gachon University) Cho, Hye-Kyung (Department of Pediatrics, Graduate School of Medicine, Gachon University) Tchah, Han (Department of Pediatrics, Graduate School of Medicine, Gachon University) Jeon, In Sang (Department of Pediatrics, Graduate School of Medicine, Gachon University) Ryoo, Eell (Department of Pediatrics, Graduate School of Medicine, Gachon University) Sun, Yong Han (Department of Pediatrics, Graduate School of Medicine, Gachon University) |
1 | Rupp ME, Fey PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003;63:353-65. DOI |
2 |
Lee B, Kang SY, Kang HM, Yang NR, Kang HG, Ha IS, et al. Outcome of antimicrobial therapy of pediatric urinary tract infections caused by extended-spectrum |
3 | Kim NH, Lee JA, Kim YK, Choi EH, Ha IS, Lee HJ, et al. Risk factors of urinary tract infections due to extendedspectrum beta-lactamase producing Escherichia coli in children. Korean J Pediatr 2004;47:164-9. |
4 |
Park C, Kim MS, Kim MK, Yim HE, Yoo KH, Hong YS, et al. Clinical significance of extended-spectrum |
5 | Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA, 2011. |
6 | Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56:52-9. DOI |
7 | Du Bois SK, Marriot MS, Amyes SG. TEM- and SHV-derived extended-spectrum beta-lactamase: relationship between selection, structure and function. J Antimicrob Chemother 1995;35:1697-704. |
8 | Kizilca O, Siraneci R, Yilmaz A, Hatipoglu N, Ozturk E, Kiyak A, et al. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int 2012;54:858-62. DOI |
9 |
Kim NH, Kim JH, Lee TJ. Risk Factors for community-onset urinary tract infections due to extended-spectrum |
10 | Chen PC, Chang LY, Lu CY, Shao PL, Tsai IJ, Tsau YK, et al. Drug susceptibility and treatment response of common urinary tract infection pathogens in children. J Microbiol Immunol Infect 2013. |
11 | Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-86. DOI |
12 | Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Perea EJ, Perez-Cano R, et al. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006;1;42:37-45. DOI |
13 | Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin Microbiol Infect 2008;14 S181-4. DOI |
14 | Elder JS. Urinary tract infections. In: Kliegman RM, Stanton BF, St.Geme JW, Schor NF, Behrman RE, eds. Nelson textbook of pediatrics.19th ed. Philadelphia, PA: Elsevier; 2011:1829-34. |
15 | Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin Microbiol Infect 2008;14 S181-4. DOI |
16 | Prajapati BS, Prajapati RB, Patel PS. Advances in management of urinary tract infections. Indian J Pediatr 2008;75:809-14. DOI |
17 | Lee JW, Shin JS, Seo JW, Lee MA, Lee SJ. Incidence and risk factors for extended-spectrum beta lactamase-producing Escherichia coli in community-acquired childhood urinary tract infection. J Korean Soc Pediatr Nephrol 2004;8:214-22. |
18 | American Academy of Pediatrics, Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011;128:595-610. DOI |
19 | Lee SY, Lee JH, Kim JH, Hur JK, Kim SM, Ma SH, et al. Susceptibility tests of oral antibiotics including cefixime against Escherichia coli , isolated from pediatric patients with community acquired urinary tract infections. Korean J Pediatr 2006;49:777-83. DOI |
20 |
Kim YK, Pai H, Lee HJ, Park SE, Choi EH, Kim J, et al. Bloodstream infections by extended-spectrum |
![]() |